FBXW7 is a haploinsufficient tumor suppressor with loss-of-function mutations occurring in human cancers. FBXW7 inactivation causes genomic instability, but the mechanism remains elusive. Here we show that FBXW7 facilitates nonhomologous end-joining (NHEJ) repair and that FBXW7 depletion causes radiosensitization. In response to ionizing radiation, ATM phosphorylates FBXW7 at serine 26 to recruit it to DNA double-strand break (DSB) sites, whereas activated DNA-PKcs phosphorylates XRCC4 at serines 325/326, which promotes binding of XRCC4 to FBXW7. SCF FBXW7 E3 ligase then promotes polyubiquitylation of XRCC4 at lysine 296 via lysine 63 linkage for enhanced association with the Ku70/80 complex to facilitate NHEJ repair. Consistent with these findings, a small-molecule inhibitor that abrogates XRCC4 polyubiquitylation reduces NHEJ repair. Our study demonstrates one mechanism by which FBXW7 contributes to genome integrity and implies that inactivated FBXW7 in human cancers could be a strategy for increasing the efficacy of radiotherapy.
In Brief FBXW7 is a tumor suppressor important for genome stability. Zhang et al. find that K63-linked polyubiquitination of XRCC4 by SCF FBXW7 enhances nonhomologous end-joining and radiation tolerance by promoting the association of XRCC4/ XLF/LigIV with Ku70/80. ATM phosphorylates FBXW7, leading to its enrichment at DNA breaks, whereas XRCC4 ubiquitylation requires phosphorylation by DNA-PKcs.
INTRODUCTION
DNA double-strand breaks (DSBs) are deleterious lesions that, when left unrepaired, can cause gross chromosomal rearrangements, genomic instability, tumorigenesis, and cell death (Jackson and Bartek, 2009) . DSB repair in mammalian cells is comprised of two major and mechanistically distinct processes: homologous recombination (HR) and nonhomologous endjoining (NHEJ). NHEJ represents the dominant and a priori DSB repair mechanism (Jeggo et al., 2011; Kakarougkas and Jeggo, 2014) . In response to DSBs, NHEJ is initiated as the Ku70/80 heterodimer binds rapidly to free DNA ends and recruits the serine/threonine kinase DNA-dependent protein kinase, catalytic subunit (DNA-PKcs), followed by recruitment of Artemis, XRCC4, Ligase IV (LigIV), and XRCC4-like factor (XLF) (Chiruvella et al., 2013; Davis and Chen, 2013; Lieber, 2010) . These repair factors, together with the recently identified PAXX (paralog of XRCC4 and XLF) (Ochi et al., 2015) efficiently mediate the stabilization, processing, and ligation of DSBs (Lieber, 2010; Ochi et al., 2014) . Defects in the core components of the NHEJ machinery, such as DNA-PKcs, LigIV, and XLF, induce radiation sensitivity (Kirchgessner et al., 1995; Shinohara et al., 2005) and genomic instability (Ferguson et al., 2000; Zha et al., 2007) . The SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase consists of the adaptor protein SKP1, the scaffold protein Cullin-1, a substrate recognizing subunit or F-box protein, and the RING component RBX1 or RBX2. Although RBX1/RBX2 is required for ligase activity by transferring the ubiquitin from an E2 to the substrate, the F-box protein determines the substrate specificity (Deshaies and Joazeiro, 2009 ). The human genome contains 69 F-box proteins (Jin et al., 2004 ) that recognize hundreds of protein substrates. By promoting the ubiquitylation of various protein substrates for targeted proteasomal degradation, SCF E3 controls many important biological processes, including cell cycle progression, DNA replication, and tumorigenesis (Jia and Sun, 2011; Nakayama and Nakayama, 2006; Zhao and Sun, 2013) . However, knowledge regarding the role of SCF E3 in DSB repair is limited, although several single-component RING-type E3 ubiquitin ligases, such as RNF8 and RNF168, have been shown to promote K63-linked ubiquitylation of histones and subsequent recruitment of DSB repair factors such as BRCA1 and 53BP1 to DSB sites (Bartocci and Denchi, 2013; Ulrich and Walden, 2010) .
FBXW7 is a well-characterized substrate recognition subunit of the SCF E3 ubiquitin ligase that has been found previously to function exclusively by K48 ubiquitylation and subsequent degradation of target proteins (Nakayama and Nakayama, 2006; Welcker and Clurman, 2008) . Several oncogenic proteins, such as Cyclin E, c-JUN, and c-MYC, are substrates for SCF FBXW7 -mediated degradation, conferring the tumor suppressor functions of FBXW7 . Likewise, loss-of-function mutation of FBXW7 is found frequently in human cancers (Akhoondi et al., 2007; Calhoun et al., 2003; Davis et al., 2014; Jones et al., 2008; Wang et al., 2014; Welcker and Clurman, 2008) . Genetic inactivation of FBXW7 causes chromosomal instability characterized by aneuploidy and micronucleus formation (Rajagopalan et al., 2004) and is associated with increased radiation-induced tumorigenesis (Mao et al., 2004) . However, whether and how FBXW7 functions in the DSB repair process for the maintenance of genomic integrity is unknown.
In this study, we found that FBXW7 enhances NHEJ repair. Upon DNA damage by ionizing radiation, FBXW7 is phosphorylated at S26 by ATM and then recruited to DSB sites where it ubiquitylates XRCC4 via K63 linkage at K296 to facilitate the association of XRCC4 with the Ku70/80 heterodimer, promoting NHEJ repair. FBXW7 inactivation via genetic or pharmacological approaches inhibits NHEJ repair and sensitizes cancer cells to radiation.
RESULTS

FBXW7a Is Recruited to DSBs in an ATM-Dependent Manner
To determine the role of FBXW7 in the maintenance of genomic integrity, we investigated its involvement in the DNA damage response and repair process because the DNA repair machinery is critical for maintaining genome stability (Ferguson et al., 2000; Zha et al., 2007) . Indeed, upon radiation, FBXW7 formed punctuate nuclear foci that partially co-localized with 53BP1 foci ( Figure 1A ). UVA laser microirradiation revealed rapid kinetics of FBXW7 recruitment to DNA damage sites, occurring as early as 1 min and peaking at 10-20 min ( Figure 1B ). Therefore, FBXW7 directly participates in the initial phase of cellular DNA damage responses by localizing to DNA damage sites. FBXW7 has three isoforms (a, b, and g) that vary only in their N-terminal region and, consequently, their subcellular localization (nucleus, cytoplasm, and nucleolus, respectively), which likely confers compartment-dependent substrate specificity (Grim et al., 2008; Welcker and Clurman, 2008) . Importantly, only the nuclear isoform FBXW7a contains two evolutionarily conserved serine/glutamine (SQ) motifs (S26 and S72), which are potential phosphorylation sites of ATM/ATR/DNA-PKcslike kinases (Figures S1A and S1B). Furthermore, only FBXW7a localizes to DNA damage sites, whereas FBXW7b and FBXW7g do not ( Figure S1C ). We then determined whether these SQ motifs unique to FBXW7a are phosphorylated in response to radiation by immunoprecipitation-coupled immunoblotting with p-S/TQ antibody. Remarkably, FBXW7 was phosphorylated rapidly within 1 min and reached maximal levels within 15-30 min post-radiation ( Figure 1C ), kinetics that are consistent with FBXW7 recruitment to DNA damage sites. We then identified the kinase(s) for FBXW7 phosphorylation using selective inhibitors against DNA-PKcs, ATM, and ATR ( Figure S1D ). Although inhibitors of DNA-PKcs and ATR had a minimal effect on FBXW7 phosphorylation at the SQ motif, the ATM inhibitor KU55933 completely eliminated radiation-induced FBXW7 phosphorylation at S/TQ sites ( Figure 1D ). Inhibition of CK1 or CDK1, two kinases predicted by computer algorithms to phosphorylate FBXW7 at S26, did not affect FBXW7 phosphorylation ( Figure S1E ), suggesting that FBXW7 is a direct substrate of ATM. Furthermore, FBXW7 localization to DNA damage sites was inhibited by KU55933 ( Figure S1F ), indicating a requirement of ATM-induced phosphorylation at the SQ motif for FBXW7 recruitment. We further confirmed the ATM requirement using genetic approaches and found that, in contrast to ATM wild-type (WT) fibroblasts, FBXW7 in ATM-null fibroblasts (derived from an ataxia-telangiectasia patient) failed to localize to DNA damage sites, whereas localization of the 53BP1 positive control was unaffected ( Figure 1E ). Finally, we defined which SQ site is phosphorylated by ATM using two FBXW7 single mutants, FBXW7-S26A and FBXW7-S72A, and found that radiation-induced FBXW7 phosphorylation was abrogated completely in the FBXW7-S26A mutant but not in the FBXW7-S72A mutant ( Figure 1F ). Consistent with this result, the phosphorylation-sensitive FBXW7-S72A mutant was recruited to microirradiation-induced DNA damage sites with an intensity similar to that of the WT, whereas recruitment of the phosphorylation-resistant FBXW7-S26A mutant was reduced remarkably, if not eliminated completely (Figure 1G) . Therefore, upon DNA damage, activated ATM phosphorylates FBXW7 on S26 to facilitate its recruitment to DNA damage sites.
FBXW7 Regulates Nonhomologous End-Joining and Radiosensitivity
We next determined the biological significance of FBXW7 recruitment to DNA damage sites using phosphorylated (S139) histone 2AX (gH2AX) as a readout (Lö brich et al., 2010) Figures S2C and S2D ). To determine whether the persistent DNA damage seen in FBXW7-deficient cells was due to defective DSB repair, we assessed the effects of FBXW7 depletion on both HR and NHEJ repair. Using a reporter of homologydirected repair as well as RAD51 focus formation, FBXW7 depletion had no effect on HR (Figures 2C and 2D and Figure S2E, respectively) . We then focused on NHEJ repair. Pancreatic cancer cells treated with non-specific or FBXW7 siRNA were transfected with linearized pEYFP DNA, and NHEJ was assessed by quantitative real-time PCR of the re-ligated EYFP sequence (Deans et al., 2006) . FBXW7 depletion significantly inhibited NHEJ in both MiaPaCa-2 ( Figure 2E ) and Panc-1 cells ( Figure S2F ). Furthermore, in pancreatic cancer cells constructed to stably express an NHEJ reporter that measures repair of an I-SceI-induced DSB by GFP expression (Mao et al., 2009 ), depletion of FBXW7 by siRNAs significantly inhibited NHEJ ( Figure 2F ; Figure S2G ). Finally, we incubated linearized plasmid DNA (EcoRI, 5 0 overhangs) with cell-free extracts (Budman and Chu, 2006) from two FBXW7 isogenic pairs of cells and found reduced end-joining products in FBXW7 À/À HCT116 and DLD1 cells ( Figure 2G ). Importantly, we found that stable expression of WT FBXW7a completely rescued the NHEJ defect observed in FBXW7 À/À cells, whereas the FBXW7a S26A mutant had significantly reduced NHEJ activity relative to the WT (Figure 2H ; Figure S2H ). To determine the biological significance of the role of FBXW7 in NHEJ repair, we assessed the effects of FBXW7 deficiency on radiation survival. In multiple cell lines (MiaPaCa-2, HCT116, Panc-1, and DLD1), FBXW7 deficiency (either via siRNA-mediated depletion or genomic deletion) caused significant radiosensitization (Figures 2I and 2J; Figures S2I and S2J) , suggesting that FBXW7 could be a target for radiosensitization of cancer cells. Taken together, our results demonstrate that ATM-dependent FBXW7 recruitment to DSB sites promotes NHEJ (but not HR) repair and survival following radiation-induced DNA damage. We also extended this observation to normal cells by assessing the effects of FBXW7 deficiency on gH2AX focus formation and NHEJ activity. Mouse Fbxw7 was depleted in mouse embryonic fibroblasts (MEFs) by Ad-Cre infection of MEF cells derived from Fbxw7 fl/fl embryos ( Figure 2K ), and human FBXW7 was depleted by siRNA silencing in human fibroblast cell lines (human foreskin fibroblasts [HFF] and MRC5) ( Figure S2K ). Cells were then synchronized in the G1 phase of the cell cycle to more clearly distinguish NHEJ defects. Fbxw7 À/À MEF cells exhibited significantly higher levels of gH2AX foci 2 hr post-radiation than Fbxw7 +/+ cells ( Figures 2K and 2L) . Similarly, depletion of FBXW7 from human fibroblast cells caused significantly higher levels of gH2AX 2 hr post-irradiation ( Figures S2L and S2M ), which is likely attributable to impaired NHEJ repair because NHEJ activity is reduced significantly in FBXW7-depleted cells ( Figures 2M and 2N ). These results demonstrate that the function of FBXW7 in NHEJ repair is maintained in normal cells.
SCF FBXW7 Promotes XRCC4 Polyubiquitylation via K63 Linkage
To determine how FBXW7 promotes NHEJ repair, we first investigated Cyclin E, an FBXW7 substrate that has been linked previously to genomic instability in FBXW7-deficient cells (Akhoondi et al., 2007) . As expected, Cyclin E protein levels were higher in FBXW7 À/À cells ( Figure S3A ). However, Cyclin E depletion did not rescue the NHEJ defect in FBXW7 À/À cells, suggesting a Cyclin E-independent mechanism ( Figure S3B ). We then focused our investigation on core NHEJ proteins and found, using immunoprecipitation assays, that, in response to radiation, FBXW7 interacted rather specifically with the LigIV/XRCC4/ XLF complex because it failed to interact with other DSB repair-associated proteins, such as MDC1 and 53BP1 (Figures 3A; Figure S3C ). Furthermore, the recruitment of other DSB repair proteins, including 53BP1 and MRE11, remained intact in FBXW7 À/À cells ( Figure S3D ). To define the direct FBXW7 binding partner in the LigIV/XRCC4/XLF complex, we searched for FBXW7-conserved binding motifs on all three proteins and identified an evolutionarily conserved putative binding motif (RNSSPED) on XRCC4 ( Figure S3E ). Indeed, in response to DNA damage, endogenous FBXW7 bound to endogenous XRCC4, as demonstrated by reciprocal co-immunoprecipitation with XRCC4 antibody ( Figure 3B ). Furthermore, FBXW7-XRCC4 binding was dependent on serine residues within the putative binding motif because their mutation (S325A and S326A) dramatically inhibited their binding ( Figure 3C ). Because FBXW7 is a substrate recognition component of the SCF E3 ubiquitin ligase, we next determined whether FBXW7 promotes XRCC4 ubiquitylation. Indeed, we found that FBXW7 mediated XRCC4 ubiquitylation in response to radiation (Figure 3D ; Figure S3F ). Furthermore, we assessed the dependency on the Cullin-1 subunit of the SCF FBXW7 and found, as anticipated, reduced XRCC4 ubiquitylation following siRNA-mediated depletion of Cullin-1 ( Figure S3G ). Consistent with the effects of FBXW7 depletion, Cullin-1 depletion also caused NHEJ inhibition ( Figure S3H ). Furthermore, Cullin-1 was found in the XRCC4-FBXW7 complex ( Figure 3B ). Together, these findings suggest that XRCC4 ubiquitylation and NHEJ activity are regulated by the SCF FBXW7 E3 ubiquitin ligase.
In all known cases, FBXW7 recognizes and binds its substrates, followed by targeted ubiquitylation and subsequent degradation (Nakayama and Nakayama, 2006; Welcker and Clurman, 2008) . We therefore examined the protein half-life of XRCC4 in both FBXW7 +/+ and FBXW7 À/À cells and found that XRCC4, like other core NHEJ proteins, was relatively stable, with a half-life of more than 18 hr ( Figure S3I ). Furthermore, depletion of FBXW7 had little, if any, effect on its half-life regardless of radiation exposure ( Figure S3J ), indicating that the binding of FBXW7 to XRCC4 did not promote its degradation. Recent studies have shown that non-proteolytic ubiquitylation at regions flanking DNA damage sites plays a crucial role in the DNA damage response, which is mediated by K63-linked ubiquitylation, a major genotoxic stress-induced modification (Chen and Sun, 2009; Ulrich and Walden, 2010) . We therefore determined the linkage site of the polyubiquitylation chain on XRCC4 using two ubiquitin mutants, K48R and K63R. We found that FBXW7 promoted K63-linked rather than K48-linked ubiquitylation of XRCC4 because K63 but not K48 mutation completely abrogated XRCC4 polyubiquitylation ( Figure 3E ). To further verify K63-linked ubiquitylation of XRCC4 by FBXW7, ubiquitin mutants were used that contained only a single WT lysine (K48 or K63) with all other lysines mutated to arginines. Similar to WT ubiquitin, the K63-only mutant showed substantial XRCC4 polyubiquitylation, whereas no XRCC4 polyubiquitylation was observed when a K48-only mutant was used ( Figure 3F ). These results are further supported by the finding that siRNA-mediated depletion of UBC13, an E2 that predominantly mediates K63-linked polyubiquitylation (Hofmann and Pickart, 1999; VanDemark et al., 2001 ), but not UBC5, an E2 for K48-linked polyubiquitylation, completely abrogated FBXW7-mediated XRCC4 polyubiquitylation ( Figure 3G ). Furthermore, UBC13 was found in the FBXW7-XRCC4 complex ( Figure 3A) , and siRNA silencing of UBC13, but not UBC5, inhibited NHEJ repair ( Figure 3H ). Taken together, these results demonstrate that FBXW7 interacts with the LigIV/XRCC4/XLF NHEJ protein complex via direct binding with XRCC4 to promote its polyubiquitylation via the K63 linkage, which may, in turn, promote NHEJ repair. Ubiquitylates XRCC4 at K296 in an ATM-and DNA-PKcs-Dependent Manner (A) In vitro ubiquitylation assays were performed by incubating purified XRCC4 with ATP, ubiquitin, E1, and E2 in the presence or absence of E2, immunoprecipitated FLAG-FBXW7, or XRCC4 followed by IB. Ub (K63R) and XRCC4 S325/326A were used as negative controls. (B) Pharmacological inhibition of DNA-PKcs or ATM by NU7441 or KU55933, respectively, inhibits XRCC4 ubiquitylation. MiaPaCa-2 cells transfected with the indicated constructs were pretreated with inhibitors (1 hr) and irradiated (7.5 Gy). XRCC4 ubiquitylation was examined by IP with HA antibody, followed by IB for the indicated proteins. (C) Depletion of DNA-PKcs or ATM impairs XRCC4 polyubiquitylation. XRCC4 polyubiquitylation was assessed in cells treated with non-specific, DNAPKcs, or ATM siRNAs. (D) K296 on XRCC4 is the ubiquitylation site of FBXW7a. Ubiquitylation of four XRCC4 lysine mutants (K271R, K285R, K296R, and K308R) was measured as described in Figure 3D . See also Figure S4 .
(G) MiaPaCa-2 cells transfected with non-specific, UBC5c, or UBC13 siRNA were further transfected with the indicated constructs and harvested 15 min post-IR for in vivo ubiquitylation assays. (H) MiaPaCa-2 cells stably expressing an NHEJ reporter were transfected with non-specific, UBC5, or UBC13 siRNA, and NHEJ repair efficiency was measured as described in Figure 2F (n = 2 independent experiments). *p < 0.05. See also Figure S3 .
SCF
FBXW7 Ubiquitylates XRCC4 at K296 in an ATM-and DNA-PKcsDependent Manner Having established XRCC4-S325/326-dependent binding between FBXW7 and XRCC4 ( Figure 3C ), which is consistent with the notion that phosphorylation of substrate binding motifs is a prerequisite for substrate recognition by an F-box protein (Zhou et al., 2013), we next determined whether XRCC4 polyubiquitylation is also dependent on S325/326 phosphorylation. Indeed, polyubiquitylation promoted by UBC13 was observed only in response to WT XRCC4, with no or substantially reduced polyubiquitylation in the S325/326A mutant ( Figure 4A ; Figure S4A ). Because DNA-PKcs is a known kinase for S325/326 phosphorylation on XRCC4 (Yu et al., 2003) , we inactivated DNA-PKcs by pharmacological (NU7441) ( Figure 4B ) or genetic (siRNA) (Figure 4C ) approaches and found a dramatic reduction in XRCC4 polyubiquitylation, indicating that radiation-induced, FBXW7-mediated XRCC4 polyubiquitylation is DNA-PKcs-dependent. As expected, ATM inactivation by KU55933 treatment or by siRNA also markedly inhibited XRCC4 polyubiquitylation (Figures 4B and 4C) via abrogation of FBXW7 phosphorylation and recruitment to DNA damage sites ( Figures 1D-1G) .
We further defined the potential lysine residue on which XRCC4 ubiquitylation occurs. Based on the available crystal structure of XRCC4 and known domains that bind to other NHEJ components (Junop et al., 2000) , we made four XRCC4 K/R mutants on evolutionarily conserved lysine residues at the C terminus with an open b sheet structure, free of binding to other NHEJ proteins ( Figure S4B ). Among all four mutants, only the K296R mutation completely abrogated FBXW7-mediated polyubiquitylation ( Figure 4D ), indicating that the K296 residue is the ubiquitylation site on XRCC4. We also found reduced XRCC4 polyubiquitylation in the K271R mutant, which is likely due to the introduction of a mutation in the nuclear localization signal motif ( Figure S4C , underlined sequence), which substantially reduced its nuclear localization ( Figure S4D ), therefore limiting its polyubiquitylation by nuclear FBXW7a. Our finding is consistent with a recent report (Fukuchi et al., 2015) . Taken together, these data demonstrate that, in response to DNA damage, FBXW7 binds to and ubiquitylates XRCC4 at K296 via K63 linkage in an ATM-and DNA-PKcs-dependent manner to promote NHEJ. (A and B) FBXW7 isogenic HCT116 cells were irradiated (7.5 Gy) and collected for co-IP assays with XRCC4 (A) or Ku80 (B) antibody, followed by IB for NHEJ proteins. (C) K296 of XRCC4 is required for association with Ku70/80. XRCC4 WT and K296R mutants were expressed in MiaPaCa-2 cells, and their interaction with endogenous NHEJ proteins after IR was examined by XRCC4 IP. (D) Purified GST-Ku70/K80 heterodimer proteins from Sf9 cells were incubated with agarose beads conjugated with tetra-ubiquitin K48 or K63, as indicated. Ku70/80 and tetra-ubiquitin chains were eluted by SDS sample buffer, followed by immunoblotting for glutathione S-transferase (GST). See also Figure S5 .
showed a reduced interaction of Ku80 with XRCC4, LigIV, and XLF in FBXW7 À/À cells ( Figure 5B ), suggesting that FBXW7-mediated XRCC4 polyubiquitylation facilitates the interaction between XRCC4/LigIV/XLF and Ku70/80 complexes. In addition, we found that XRCC4 polyubiquitylation is required for XRCC4 to form a complex with Ku70/80 because the ubiquitin site mutant XRCC4-K296R failed to bind to Ku80 and displayed substantially reduced binding to Ku70, whereas binding with LigIV and XLF was unaltered ( Figure 5C ). Finally, having established that XRCC4 ubiquitylation promotes XRCC4 and Ku70/80 interaction, we assessed the ability of Ku70/80 to bind to synthetic tetra-ubiquitin peptides with different lysine linkages and found that Ku70/80 directly bound K63-linked tetra-ubiquitin with very minimal binding to K48-linked tetra-ubiquitin ( Figure 5D ), suggesting that the interaction between ubiquitylated XRCC4 and Ku70/80 is through a K63 linkage ubiquitin binding domain in Ku70/80.
Ubiquitylation at K296 Promotes XRCC4 Chromatin Association, NHEJ Repair, and Radiation Survival We next determined the effect of FBXW7 on recruitment and/or retention of XRCC4 to DSBs by measuring GFP-XRCC4 localization to microirradiation-induced DNA damage sites. Although GFP-XRCC4 was recruited rapidly to DNA damage sites (within 60 s) in both FBXW7 +/+ and FBXW7 À/À cells, the amount of XRCC4 recruited, as reflected by fluorescence intensity along the laser track, was reduced significantly in the absence of FBXW7 ( Figure 6A ). Furthermore, the K296R mutant also displayed significantly reduced recruitment to DNA damage sites ( Figure 6B ). Consistent with these data, chromatin fractionation studies revealed decreased chromatin binding of the XRCC4-K296R mutant in response to radiation-induced DNA damage ( Figure 6C ) as well as reduced XRCC4 chromatin binding in FBXW7 À/À cells following radiation ( Figure S6A ). These data provide evidence from two independent endpoints, showing that (B) K296R mutation impairs the recruitment of GFP-XRCC4 to DNA damage sites. GFP-XRCC4 WT and K296R were expressed in MiaPaCa-2 cells, and their localization to microIR DNA damage sites was monitored post-microIR. (C) XRCC4 isogenic HCT116 cells, XRCC4 WT, and K296R stable cells were treated with or without IR (6 Gy) and harvested at various time points for the isolation of non-chromatin and chromatin fractions, followed by immunoblot analysis. (D) NHEJ activity was assessed in XRCC4 isogenic HCT116 cells stably expressing XRCC4 WT or S325/326 or K296R mutants as described in Figure 2D (data are the mean ± SE of three independent experiments).
(E) XRCC4 isogenic HCT116 cells as well as derived XRCC4 WT, S325/326A, and K296R stable cells were irradiated and, 24 hr later, processed for clonogenic survival. Data are presented as mean ± SD of four repeats. Scale bars, 10 mm. *p < 0.05, ***p < 0.001. See also Figure S6 . , or K63R HA-ubiquitin were pre-treated with MLN4924 (300 nM) for 6 hr, followed by IR (6 Gy) and collection for IP (15 min post-IR) with HA antibody, followed by IB. (B) MiaPaCa-2 cells were treated with drugs for the indicated times, followed by cell-free extract preparation. The linearized-pBlueScript vector (by EcoRI digestion) was incubated with the extracts for 2 hr. Reactions were subjected to agarose gel electrophoresis. (C) Cells stably expressing the I-SceI NHEJ reporter were pre-treated for 1 hr with MLN4924, followed by infection with adenovirus expressing I-SceI and continued MLN4924 treatment for 24 hr. GFP-positive cells, indicative of NHEJ repair, were quantitated by flow cytometry.
(legend continued on next page)
FBXW7 is required for efficient recruitment of XRCC4 to DNA damage sites.
To determine the functional consequences of mutations on the sites of XRCC4 phosphorylation and ubiquitylation, we performed a rescue experiment by measuring NHEJ activity in XRCC4 À/À cells expressing the WT or the XRCC4 mutants S325/326A and K296R along with a vector control ( Figure S6B ). WT XRCC4 completely rescued NHEJ, as expected, whereas the XRCC4 mutants S325/326A and K296R conferred partial rescue, as evidenced by significantly reduced NHEJ activity (Figure 6D) . The biological effects of XRCC4 mutation (K296 or S325/ 326) were assessed in radiation survival assays, which demonstrated that XRCC4 S325/326A and K296R are compromised in their ability to rescue radiosensitization relative to WT XRCC4 in XRCC4 À/À cells ( Figure 6E ). It is worth noting that depletion of XRCC4, a core component of the NHEJ complex, renders cells more sensitive to radiation than depletion of FBXW7, which acts as a facilitator of NHEJ repair, as evidenced by greater radiosensitization in XRCC4-null cells than in FBXW7-null cells (RER 2.2 versus 1.5, respectively; Figures 6E and 2I) as well as more severe defects in DNA damage repair, as reflected by gH2AX positivity ( Figure S6C ) and NHEJ activity ( Figures 2M  and 2N ). Taken together, these results clearly demonstrate that FBXW7-mediated XRCC4 polyubiquitylation at K296 facilitates XRCC4 interactions with Ku70/80 and its recruitment to chromosomal DSBs for effective NHEJ repair and survival following radiation-induced DNA damage.
Pharmacological Inhibition of SCF FBXW7 Leads to Defective NHEJ To determine whether the functions of SCF FBXW7 in NHEJ repair could be targeted pharmacologically, we utilized MLN4924, a small-molecule inhibitor of the NEDD8-activating enzyme, currently in phase 1-2 clinical trials, that inhibits Cullin-1 neddylation and, therefore, SCF activity (Nawrocki et al., 2012; Soucy et al., 2009; Zhao et al., 2014) . Indeed, MLN4924 effectively abrogated FBXW7-mediated K63-linked polyubiquitylation of XRCC4 ( Figure 7A ; Figure S7A ) and inhibited NHEJ repair under concentrations at which cullin neddylation was abrogated nearly completely but with little to no effect on the levels of core NHEJ proteins ( Figure 7B ; Figures S7B and S7C ). MLN4924 also inhibited NHEJ in a concentration-dependent manner in other independent NHEJ repair assays and with an activity comparable with the DNA-PKcs inhibitor NU7441 (Zhao et al., 2006; Figures 7C and 7D; Figures S7D and S7E) . The effect of MLN4924 on NHEJ was greater in cells expressing FBXW7 than in cells depleted of FBXW7 ( Figure 7E ), supporting the involvement of the FBXW7/XRCC4 axis in NHEJ inhibition by MLN4924. Finally, MLN4924 reduced the binding between XRCC4 and Ku70/80 ( Figure S7F ). Collectively, these findings are consistent with our previous studies demonstrating that MLN4924 induces significant radiosensitization of cancer cells both in vitro and in vivo in association with persistent DSBs (Wei et al., 2012) . Furthermore, these findings demonstrate that MLN4924 can be used to inhibit K63-linked ubiquitylation and NHEJ repair.
DISCUSSION
FBXW7 is a prototypical tumor suppressor that is inactivated in many human cancers, and its inactivation is associated with reduced patient survival Wang et al., 2014; Welcker and Clurman, 2008) . The tumor suppressor function of FBXW7 is thought to be attributable to its degradation of a number of oncogenic proteins, including c-JUN, c-MYC, Cyclin E, Notch, and MCL-1 Wang et al., 2014; Welcker and Clurman, 2008) . On the other hand, it has been known for more than a decade that FBXW7 is required for the maintenance of genomic stability (Rajagopalan et al., 2004) , but how FBXW7 acts in that regard is unknown, although accumulation of Cyclin E and Aurora A has been implicated (Perez-Losada et al., 2005; Rajagopalan et al., 2004) . Here we report a Cyclin E-independent function of FBXW7. Instead, in our system, FBXW7 preserves genomic integrity by localizing to DNA damage sites, where it promotes polyubiquitylation of phospho-XRCC4 via K63 linkage to enhance Ku70/80 binding, therefore facilitating NHEJ repair. We provide the following evidence to support this conclusion.
(1) Upon radiation-induced DNA damage, FBXW7 is phosphorylated at S26 by ATM and recruited rapidly to DNA damage sites.
(2) XRCC4 is phosphorylated by DNA-PKcs at S325/S326, which facilitates FBXW7 binding. (3) SCF FBXW7 then promotes XRCC4 polyubiquitylation at K296 via K63 linkage. (4) Polyubiquitylated XRCC4 has enhanced interaction with the Ku70/80 complex and DNA damage sites to promote NHEJ repair, whereas the ubiquitin-resistant XRCC4-K296R mutant, the recruitment-deficient FBXW7-S26A mutant, and the phosphorylation-resistant XRCC4-S325A/S326A mutant have significantly reduced NHEJ repair capacity. (5) Inactivation of FBXW7 via genetic or pharmacological approaches abrogates NHEJ repair and renders cells more sensitive to DNA-damaging agents such as ionizing radiation. Here we report the direct involvement of FBXW7 in DSB repair and provide evidence that FBXW7 can cause substrate polyubiquitylation via K63 linkage for functional modulation. Our study supports the working model shown in Figure 7F and further suggests that FBXW7 inactivation by either loss-of-function mutation or pharmacological inhibition could increase the efficacy of radiotherapy of human cancers. This is supported by (D) Cells were pre-treated with drugs for 1 hr, transfected with linearized pEYFP plasmid (by NheI digestion), and analyzed by qPCR 12 hr later for the ligated pEYFP region normalized to an uncut flanking DNA sequence. (E) MiaPaCa-2 cells expressing the I-SceI NHEJ reporter were treated with non-specific or FBXW7 siRNA and MLN4924. Data are the normalized mean percentage of MLN4924 inhibition for each RNAi condition. siFBXW7 alone caused 30% NHEJ inhibition relative to siNS. (F) Proposed model for FBXW7 regulation of NHEJ. In response to radiation-induced DSBs, FBXW7a is phosphorylated (at S26) by ATM, leading to its recruitment to DSB sites. Locally enriched FBXW7 recognizes phosphorylated XRCC4 (by DNA-PKcs at S325/326) and, together with other components of the SCF E3 ubiquitin ligase, promotes K63-linked polyubiquitylation of XRCC4 at K296. Polyubiquitylated XRCC4 facilitates the association of XRCC4 (and LigIV/XLF) with the Ku70/80 heterodimer and DSBs to form an active NHEJ complex for effective repair. Pharmacologic (by MLN4924) or genetic (siRNA or genomic deletion) inactivation of FBXW7a inhibits this pathway, resulting in impaired NHEJ, persistent DSBs, and increased radiation sensitivity. Data are the mean ± SD/SE of two (E) or three (C and D) independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S7 . the findings that FBXW7 mutation is associated with increased radiosensitivity ( Figure S7G ) and that pharmacological inhibition of SCF FBXW7 induces radiosensitization (Wei et al., 2012) .
Involvement of SCF E3 ubiquitin ligases in DSB repair has been implicated in a few recent studies. For example, Cullin-1 depletion leads to DSBs and gH2AX focus formation (Cukras et al., 2014) . Removal of Ku from DSBs following NHEJ is neddylation-dependent and blocked by MLN4924 treatment (Brown et al., 2015) . More specifically, SCF SKP2 has been found to mediate K63-linked ubiquitylation of NBS1 to promote its association with ATM to enhance HR repair (Wu et al., 2012) . SCF b-TRCP has been reported to promote degradation of XLF to disrupt the XRCC4/XLF/LigIV complex and abrogate NHEJ . Our finding provides yet another mechanism by which SCF FBXW7 E3 ubiquitin ligase regulates genomic stability and DNA repair by promoting XRCC4 polyubiquitylation via K63 linkage for effective NHEJ repair. NHEJ is a major repair pathway for DSBs, and its defect causes radiation sensitivity and genomic instability (Rooney et al., 2003; Woodbine et al., 2014) . NHEJ repair is tightly regulated by a series of interactions between two core complexes of the machinery, including the Ku70/80 heterodimer/DNAPKcs complex and the XRCC4/Lig IV/XLF complex (Mari et al., 2006; Ochi et al., 2014) . However, the mechanisms by which these proteins assemble into functional protein-DNA complexes remain elusive (Ochi et al., 2014; Radhakrishnan et al., 2014; Williams et al., 2014) . It has been demonstrated that the direct association of Ku70 and XRCC4 is weak in biochemical assays (Mari et al., 2006) . Our finding, therefore, provides a mechanism by which SCF FBXW7 -mediated XRCC4 polyubiquitylation could enhance the binding of XRCC4 to the Ku70/80 heterodimer to facilitate NHEJ repair in response to DSBs. XRCC4 is a nuclear phosphoprotein that is phosphorylated by DNA-PKcs in response to radiation (Critchlow et al., 1997) . A prior study examined the function of these phosphorylation sites in the radiation survival of XR-1 cells (a DSB repair mutant cell line derived from Chinese hamster ovary [CHO] cells that lacks Xrcc4) and found that expression of Xrcc4 containing a combination of six serine-to-alanine mutations (including S325/326A) was able to rescue radiation survival in this model (Yu et al., 2003) . Ubiquitylation of XRCC4 has also been reported previously, and an increase in the abundance of ubiquitylated XRCC4 has been observed when cells were exposed to genotoxic stress (Foster et al., 2006) . Until now, however, the function of XRCC4 ubiquitylation and the E3 ligase responsible for XRCC4 ubiquitylation was unknown. Our study clearly demonstrates that, upon DNA damage, activated DNA-PKcs phosphorylates XRCC4 at S325/326 to facilitate its binding to FBXW7 for targeted polyubiquitylation by SCF FBXW7 E3 ligase.
We have shown previously that the NEDD8-activating enzyme inhibitor MLN4924 sensitizes pancreatic cancer cells to radiation via inhibition of SCF ligase activity, resulting in accumulation of the SCF substrates CDT1 and WEE1 (Wei et al., 2012) . Similarly, others have shown that the accumulation of proteins involved in DNA replication, DNA damage response, and repair is critical to the lethality of MLN4924 (Blank et al., 2013; Garcia et al., 2014) . In contrast to these studies, which largely implicate inhibition of K48-linked ubiquitylation and protein degradation to the activity of MLN4924, we show here that MLN4924 can also modulate K63-linked ubiquitylation. This finding shows yet another mechanism of MLN4924: inhibiting NHEJ repair to induce radiosensitization. Therapeutically, MLN4924 has been utilized to inhibit protein degradation of Cullin-RING ligase substrates because of K48-linked ubiquitylation (Soucy et al., 2009; Zhao et al., 2014) . Given the emerging non-proteolytic functions of SCF E3 ubiquitin ligases in DSB repair, described in this and one prior report (Wu et al., 2012) , MLN4924 represents an important therapeutic strategy for inhibiting both NHEJ (via SCF FBXW7 ) and, potentially, HR (via SCF SKP2 ) and sensitizing tumor cells to DNA damage. Finally, the concentration-dependent inhibition of NHEJ by MLN4924 in FBXW7-null cells ( Figure 7E ) suggests the involvement of other Cullin-RING ligase (CRL) substrates.
FBXW7 is a tumor suppressor whose loss-of-function mutations, which are found frequently in human cancers, would cause accumulation of oncogenic substrates such as Cyclin E, c-JUN, c-MYC, MCL-1, and Notch to promote tumorigenesis . Notably, unlike depletion of core NHEJ proteins, which causes severe radiation sensitivity, depletion of FBXW7 leads to moderate but significant radiation sensitivity. This is likely due to the counteracting effect of accumulation of other FBXW7 substrates such as c-MYC, MCL-1, and Notch, which confer radioresistance (Theys et al., 2013; Wang et al., 2010 Wang et al., , 2013 Wei et al., 2015) . Nevertheless, we show that abrogation of K63-linked polyubiquitylation of XRCC4 upon FBXW7 inactivation is an important contributor to cellular radiation sensitivity that overcomes the radioresistant effect of other FBXW7 substrates, resulting in a net outcome of radiosensitization.
In summary, our study not only identifies functions of FBXW7 in regulating NHEJ but also provides a rationale for enhancing the efficacy of radiation therapy by FBXW7 inactivation. Specifically, human cancer cells with loss-of-function mutations in FBXW7 or pharmacologically inactivated FBXW7 might be more sensitive to radiation and, possibly, other DNA-damaging chemotherapies because of defective NHEJ repair.
EXPERIMENTAL PROCEDURES
Animal Study Approval All procedures were approved by the University of Michigan Committee on the Use and Care of Animals. Animal care was provided in accordance with the principles and procedures outlined in the National Research Council Guide for the Care and Use of Laboratory Animals.
Immunofluorescence
For immunofluorescence experiments, cells were grown and treated on coverslips in 12-well dishes. Following treatment, cells were fixed and stained as described previously (Karnak et al., 2014) with antibodies recognizing gH2AX, 53BP1 (Millipore), RAD51 (GeneTex), or MRE11 (Cell Signaling Technology) and DAPI. Samples were imaged with an Olympus IX71 FluoView confocal microscope (Olympus America) with a 603 oil objective. Fields were chosen at random based on DAPI staining. For quantitation of RAD51 and gH2AX foci, at least 100 cells from each treatment condition were scored. Cells with five or more RAD51 foci were scored as positive.
Microirradiation
Cells were seeded onto glass-bottom dishes (MatTek) and transfected with pEGFP-FBXW7a (WT and mutants) or pEGFP-XRCC4 (WT and mutants). GFP-positive cells were then irradiated with a 365-nm UVA laser focused through a 603/1.2-W objective using a Zeiss Axiovert equipped with LSM 520 Meta. UVA (4.36 J/m2) was introduced to an area of approximately 12 3 0.1 mm. Images were captured at 1 min intervals.
Ubiquitylation Assays
In vivo and in vitro ubiquitylation assays were performed as described previously (Wu et al., 2012; Zhao et al., 2011) . For in vivo ubiquitylation assays, MiaPaCa-2 cells were transfected with the indicated plasmids for 48 hr and then harvested in cell lysis buffer. The cell extracts were then incubated with hemagglutinin (HA) beads for 3 hr, washed, and subjected to immunoblot analysis. For in vitro ubiquitylation assays, HA-XRCC4 proteins and the FLAG-FBXW7a-SCF complex isolated from MiaPaCa-2 cell lysates were incubated with 0.5 mg E1 (Boston Biochem), 1.5 mg ubiquitin (Boston Biochem), 1 mg UBC13/UEV1A (Boston Biochem), and 2.5 mM ATP in a final 30 ml reaction buffer (1.5 mM MgCl 2 , 5 mM KCl, 1 mM DTT, 20 mM HEPES [pH 7.4]) at 30 C for 2 hr. XRCC4 ubiquitylation was detected by immunoblotting.
NHEJ Assay in Cell-free Extracts
The NHEJ assay was performed as described, with modifications (Pfeiffer et al., 2014; Sharma and Raghavan, 2010 .5], 75 mM NaCl, 10 mM MgCl 2 , 42.5 mM KCl, 0.025% Triton X-100, 100 mg/ml BSA, 10% polyethylene glycol (PEG), and 5% glycerol) in a reaction volume of 10 ml at 25 C for 2 hr. Reactions were terminated by addition of EDTA (10 mM), and products were purified by phenol-chloroform extraction followed by precipitation. Reaction products were purified and resolved on a 2% agarose gel and visualized by ethidium bromide staining.
NHEJ Linearized Plasmid Assay
For the linearized plasmid-based end-joining assay, pEYFP-N1 (Clontech Laboratories) was linearized by digestion between the promoter and coding sequence of EYFP with NheI. The linear products were gel-purified and transfected into serum-starved (overnight) cells. After 12 hr, the cells were harvested and lysed to isolate transfected plasmids. The efficiency of endjoining repair was assessed by qPCR of the ligated EYFP region, normalized to an uncut flanking DNA sequence, relative to control siRNA-or DMSOtreated cells.
NHEJ I-SceI Reporter Assay
The I-SceI-based NHEJ assay was performed as described earlier with modifications (Mao et al., 2009) . Cells stably expressing the NHEJ reporter were seeded in 12-well plates. Cells transfected with various siRNAs or treated with different drugs were infected with I-SceI-expressing adenovirus. The medium was changed (with drugs) after 18 hr to avoid adenovirus toxicity. Cells were harvested after 24 hr and the percentage of GFP-positive cells (indicative of NHEJ repair) was quantitated by flow cytometry.
Statistics Statistically significant differences for the clonogenic survival and immunofluorescence assays were determined by one-way ANOVA with the Tukey postcomparison test in GraphPad PRISM version 5 (GraphPad). For gH2AX, NHEJ, and HR assays, a Student's two-tailed t test was performed in GraphPad PRISM. Figure S1 . ATM-dependent phosphorylation of FBXW7α at Ser26 mediates its recruitment to DNA damage sites (Related to Figure 1 Zhang et al. causes NHEJ inhibition (Related to Figure 7 ).
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